HAP Trading’s Nektar Therapeutics NKTR Stock Holding History

HAP Trading’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-7,914	Closed	-$4.78M	–	1248
2018 Q3	$7.24M	Buy	7,914 +1,802	+29%	+$1.54M	0.46%	52
2018 Q2	$4.48M	Buy	+6,112	New	+$7.05M	0.22%	78

Other funds holding NKTR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

HAP Trading's NKTR Position: Q4 2018 in Review

HAP Trading sold out of Nektar Therapeutics (NKTR) in Q4 2018, closing a stake of 7,914 shares — an estimated $4.78M sold.

HAP Trading first reported a position in NKTR in Q2 2018 and held it in 2 quarters. The position peaked at $7.24M in Q3 2018. 343 funds tracked by Wall St. Rank hold NKTR as of Q4 2018.

HAP Trading reported no remaining Nektar Therapeutics position as of Q4 2018 after selling out during the quarter.
HAP Trading sold 7,914 Nektar Therapeutics shares in Q4 2018, an estimated $4.78M.
HAP Trading first reported a position in Nektar Therapeutics in Q2 2018 and held it in 2 quarters.
HAP Trading's Nektar Therapeutics position peaked at $7.24M in Q3 2018.
343 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2018.

Based on HAP Trading's 13F filing for Q4 2018, filed 12 Feb 2019.